Bill

Bill > HB1031


MD HB1031

MD HB1031
Correctional Services - Medication-Assisted Treatment


summary

Introduced
02/05/2024
In Committee
02/05/2024
Crossed Over
Passed
Dead
04/08/2024

Introduced Session

2024 Regular Session

Bill Summary

Repealing the requirement that each local correctional facility make available at least one formulation of each FDA-approved full opioid agonist, partial opioid agonist, and long-acting opioid antagonist used for the treatment of opioid use disorders; requiring the Maryland Secretary of Health to annually provide each county a grant equal to the costs incurred by the county for the implementation of a certain medication-assisted treatment program; and expanding the authorized uses of the Opioid Restitution Fund.

AI Summary

This bill repeals the requirement that each local correctional facility make available at least one formulation of each FDA-approved medication used for treating opioid use disorder. Instead, it requires the Maryland Secretary of Health to annually provide each county a grant equal to the costs incurred by the county for implementing a medication-assisted treatment program in its correctional facilities. The bill also expands the authorized uses of the Opioid Restitution Fund to include providing grants to counties for implementing medication-assisted treatment programs in correctional facilities.

Committee Categories

Justice

Sponsors (1)

Last Action

House Judiciary Hearing (13:00:00 3/7/2024 ) (on 03/07/2024)

Bill Topics

Health
  • ‐ Drug Abuse, Treatment, and Education
Law, Crime, and Family Issues
  • ‐ Prisons and Correctional Institutions

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Document Type Source Location Created
State Bill Page https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1031?ys=2024RS 02/06/2024
BillText https://mgaleg.maryland.gov/2024RS/bills/hb/hb1031f.pdf 02/06/2024
Loading...